Figure S1: Expression of NKCC1 in the developing mouse and human lung Expression of NKCC1 was visualised using DAB (brown straining) in E12.5 mouse lungs (left panel) and week 9 -11 human fetal lung (right panel) epithelium. Sections were counterstained with Harris' hematoxylin (blue staining). Negative controls were carried out in serial sections by substituting the primary antibody with an isotype control (inset). Arrowheads show basolateral expression and open arrows show expression in the mesenchyme. Scale bar = 100 µm.
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Figure S1: Expression of NKCC1 in the developing mouse and human lung
Expression of NKCC1 was visualised using DAB (brown straining) in E12.5 mouse lungs (left panel) and week 9 -11 human fetal lung (right panel) epithelium. Sections were counterstained with Harris' hematoxylin (blue staining). Negative controls were carried out in serial sections by substituting the primary antibody with an isotype control (inset). Paraffin-embedded, 5 µm-thick sections from week 10 human fetal lungs were dewaxed and used for immunohistochemistry. Expression of the CLCN2 and CLCA1 were visualised using DAB (brown straining) in the lung epithelium. Sections were counterstained with Harris' hematoxylin (blue staining). Negative controls were carried out on serial sections by substituting the primary antibody with an isotype control (inset). Scale bar = 100 µm.
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